Monadelphous Group Ltd (MND.AX) stock: key figures, P/E, revenue and dividend
Industrials · Australia · ISIN AU000000MND5
Monadelphous Group Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 2.16 bn AUD | 2.79 bn AUD |
| Gross profit | 163.00 m AUD | 220.00 m AUD |
| EBIT | 103.00 m AUD | 149.00 m AUD |
| Net income | 83.00 m AUD | 127.00 m AUD |
| Diluted EPS – continuing operations | 0.83 AUD | 1.25 AUD |
Full history since 1989, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Monadelphous Group Ltd
Monadelphous Group Limited, an engineering group, provides construction, maintenance, and industrial services to resources, energy, and infrastructure sectors in Australia, China, Mongolia, Papua New Guinea, China, Vietnam, the Philippines, and internationally. It offers project management and construction services; earthworks, structural concrete and inground services, modularization, structural, mechanical, piping, heavy lift, electrical and instrumentation, commissioning, demolition, design and construction of non-process infrastructure, high voltage electrical construction, and balance-of-plant design and construction of renewable energy developments; process and non-process maintenance services; and front-end scoping, shutdown planning, management, and execution of mechanical and electrical maintenance services, shutdowns, sustaining capital works, fixed plant maintenance services, access solutions, specialist coatings, rail maintenance, and high-voltage electrical maintenance services. In addition, it offers turnkey heavy lift solutions, and civil and electrical services. Monadelphous Group Limited was founded in 1972 and is headquartered in Perth, Australia.
More stocks
- Immunome Inc. (IMNM)
- Fleury S.A. (FLRY3.SA)
- Henan Lingrui Pharmaceutical Co Ltd (600285.SS)
- KCC Corporation (002380.KS)
- Gempharmatech Co. Ltd. A (688046.SS)
- Shenzhen Overseas Chinese Town Co Ltd (000069.SZ)
- Teijin Ltd (3401.T)
- VGP NV (VGP.BR)
- Yipinhong Pharmaceutical Co Ltd Class A (300723.SZ)
- Pan Ocean Co Ltd (028670.KS)
- Boyd Group Services Inc (BYD.TO)
- Zhuzhou Kibing Group Co Ltd (601636.SS)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.